UniSA’s involvement in a new joint laboratory will see a team of researchers in South Australia work on the science that will lead to a better understanding of cancer and improved treatments.
UniSA and SA Pathology’s Centre for Cancer Biology (CCB) is partnering with Singapore’s Institute of Molecular and Cell Biology (IMCB) within the Agency for Science Technology and Research (A*STAR), thanks to $1 million in support from the Department of State Development through its South Australian Research Fellowship Program.
Under the Fellowship, international expert in the relationship between chronic inflammation and the development of cancers – Professor Vinay Tergaonkar – will lead the new laboratory. He will lead cutting-edge research into inflammation in a variety of cancers and the development of new drug treatments to block inflammation selectively, rather than generically.
Vice Chancellor, Professor David Lloyd says the partnership is a perfect example of how international collaborations can benefit South Australia and sow the seeds for future industries.
“This is a significant investment by the University and the State Government but one that will continue to reap great rewards by building the State’s potential for national and international leadership in aspects of cancer research,” Prof Lloyd says.
“Prof Tergaonkar’s appointment with UniSA has already underpinned a successful infrastructure grant of $2 million from the Australian Cancer Research Foundation and attracted support from the Cancer Council SA and other funding bodies.”
Prof Lloyd says the collaboration provides access to scientific expertise, equipment, and the sharing of data, and will support continuing research exchange opportunities between SA and Singapore, nurturing higher degree research students to undertake research into cancer therapies.
Prof Tergaonkar said the new laboratory is a real indicator of CCB’s and South Australia’s world class program and its growing reputation internationally to create partnerships, like they have with IMBC and A*STAR.
“The number of research partners and quality of the relationships that exist at CCB is delivering results that provide breakthroughs in the discovery of causes of cancer and how to prevent and treat the disease in people,” Prof Tergaonkar says.
“Institutions coming together like we are here in Adelaide, demonstrates the trust that exists between the CCB and Singapore, and sends a message to prospective partners about getting involved in South Australia to be part of the work being done.”